The primary effects of IL-1 in chronic kidney disease (CKD) are related to mineral and bone disorders [61], but IL-1 also plays a role as a potential mediator of inflammation in heart failure and the cardiovascular complications associated with CKD [62]. Here, IL1B is linked to bone disorder.